Shenzhen Neptunus Interlong Bio-technique Balance Sheet Health
Financial Health criteria checks 5/6
Shenzhen Neptunus Interlong Bio-technique has a total shareholder equity of CN¥1.1B and total debt of CN¥89.4M, which brings its debt-to-equity ratio to 8.5%. Its total assets and total liabilities are CN¥1.4B and CN¥367.6M respectively. Shenzhen Neptunus Interlong Bio-technique's EBIT is CN¥60.6M making its interest coverage ratio 157. It has cash and short-term investments of CN¥391.9M.
Key information
8.5%
Debt to equity ratio
CN¥89.40m
Debt
Interest coverage ratio | 157x |
Cash | CN¥391.95m |
Equity | CN¥1.06b |
Total liabilities | CN¥367.57m |
Total assets | CN¥1.43b |
Recent financial health updates
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?
Nov 07These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely
Oct 03Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?
Mar 29We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt
Sep 28Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?
Jun 06Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?
Dec 15Recent updates
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?
Nov 07Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings
Sep 05We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings
Apr 19These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely
Oct 03Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?
Mar 29We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt
Sep 28A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Aug 18Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?
Jun 06Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?
Dec 15Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.
Dec 29Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly
Nov 24Financial Position Analysis
Short Term Liabilities: 8329's short term assets (CN¥930.7M) exceed its short term liabilities (CN¥330.8M).
Long Term Liabilities: 8329's short term assets (CN¥930.7M) exceed its long term liabilities (CN¥36.8M).
Debt to Equity History and Analysis
Debt Level: 8329 has more cash than its total debt.
Reducing Debt: 8329's debt to equity ratio has increased from 4.8% to 8.5% over the past 5 years.
Debt Coverage: 8329's debt is well covered by operating cash flow (142.3%).
Interest Coverage: 8329's interest payments on its debt are well covered by EBIT (157x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/10 20:36 |
End of Day Share Price | 2025/01/10 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shenzhen Neptunus Interlong Bio-technique Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|